메뉴 건너뛰기




Volumn 111, Issue 8, 2012, Pages 445-451

Impact of vaccination with seven-valent pneumococcal conjugate vaccine on virologic and immunologic outcomes among HIV-infected adult patients in the era of highly active antiretroviral therapy

Author keywords

Antiretroviral therapy; Highly active antiretroviral therapy; HIV infection; HIV RNA load; Pneumococcal conjugate vaccine; Streptococcus pneumoniae

Indexed keywords

PNEUMOCOCCUS VACCINE;

EID: 84865575281     PISSN: None     EISSN: 09296646     Source Type: Journal    
DOI: 10.1016/j.jfma.2011.06.027     Document Type: Article
Times cited : (8)

References (28)
  • 1
    • 0026633235 scopus 로고
    • Pneumococcal disease during HIV infection. Epidemiologic, clinical, and immunologic perspectives
    • Janoff E.N., Breiman R.F., Daley C.L., Hopewell P.C. Pneumococcal disease during HIV infection. Epidemiologic, clinical, and immunologic perspectives. Ann Intern Med 1992, 117:314-324.
    • (1992) Ann Intern Med , vol.117 , pp. 314-324
    • Janoff, E.N.1    Breiman, R.F.2    Daley, C.L.3    Hopewell, P.C.4
  • 2
    • 0036568943 scopus 로고    scopus 로고
    • Recurrent invasive pneumococcal disease in individuals with human immunodeficiency virus infection
    • McEllistrem M.C., Mendelsohn A.B., Pass M.A., Elliott J.A., Whitney C.G., Kolano J.A., et al. Recurrent invasive pneumococcal disease in individuals with human immunodeficiency virus infection. J Infect Dis 2002, 185:1364-1368.
    • (2002) J Infect Dis , vol.185 , pp. 1364-1368
    • McEllistrem, M.C.1    Mendelsohn, A.B.2    Pass, M.A.3    Elliott, J.A.4    Whitney, C.G.5    Kolano, J.A.6
  • 4
    • 38749092568 scopus 로고    scopus 로고
    • Invasive pneumococcal disease in an underimmunized, high HIV prevalence population
    • Tasslimi A., Wenger P., Pentakota S.R., Brimacombe M., Burday M., Sinha A. Invasive pneumococcal disease in an underimmunized, high HIV prevalence population. J Infect 2008, 56:99-102.
    • (2008) J Infect , vol.56 , pp. 99-102
    • Tasslimi, A.1    Wenger, P.2    Pentakota, S.R.3    Brimacombe, M.4    Burday, M.5    Sinha, A.6
  • 5
    • 0025089765 scopus 로고
    • The role of human immunodeficiency virus infection in pneumococcal bacteremia in San Francisco residents
    • Redd S.C., Rutherford G.W., Sande M.A., Lifson A.R., Hadley W.K., Facklam R.R., et al. The role of human immunodeficiency virus infection in pneumococcal bacteremia in San Francisco residents. J Infect Dis 1990, 162:1012-1017.
    • (1990) J Infect Dis , vol.162 , pp. 1012-1017
    • Redd, S.C.1    Rutherford, G.W.2    Sande, M.A.3    Lifson, A.R.4    Hadley, W.K.5    Facklam, R.R.6
  • 6
    • 2942567821 scopus 로고    scopus 로고
    • Invasive pneumococcal disease in patients infected with HIV: still a threat in the era of highly active antiretroviral therapy
    • Jordano Q., Falco V., Almirante B., Planes A.M., del Valle O., Ribera E., et al. Invasive pneumococcal disease in patients infected with HIV: still a threat in the era of highly active antiretroviral therapy. Clin Infect Dis 2004, 38:1623-1628.
    • (2004) Clin Infect Dis , vol.38 , pp. 1623-1628
    • Jordano, Q.1    Falco, V.2    Almirante, B.3    Planes, A.M.4    del Valle, O.5    Ribera, E.6
  • 7
    • 65549121051 scopus 로고    scopus 로고
    • Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America
    • quiz CE1-4
    • Kaplan J.E., Benson C., Holmes K.H., Brooks J.T., Pau A., Masur H. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2009, 58:1-207. quiz CE1-4.
    • (2009) MMWR Recomm Rep , vol.58 , pp. 1-207
    • Kaplan, J.E.1    Benson, C.2    Holmes, K.H.3    Brooks, J.T.4    Pau, A.5    Masur, H.6
  • 8
    • 0034715306 scopus 로고    scopus 로고
    • Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patients
    • Breiman R.F., Keller D.W., Phelan M.A., Sniadack D.H., Stephens D.S., Rimland D., et al. Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patients. Arch Intern Med 2000, 160:2633-2638.
    • (2000) Arch Intern Med , vol.160 , pp. 2633-2638
    • Breiman, R.F.1    Keller, D.W.2    Phelan, M.A.3    Sniadack, D.H.4    Stephens, D.S.5    Rimland, D.6
  • 9
    • 2342597188 scopus 로고    scopus 로고
    • Clinical experience of the 23-valent capsular polysaccharide pneumococcal vaccination in HIV-1-infected patients receiving highly active antiretroviral therapy: a prospective observational study
    • Hung C.C., Chen M.Y., Hsieh S.M., Hsiao C.F., Sheng W.H., Chang S.C. Clinical experience of the 23-valent capsular polysaccharide pneumococcal vaccination in HIV-1-infected patients receiving highly active antiretroviral therapy: a prospective observational study. Vaccine 2004, 22:2006-2012.
    • (2004) Vaccine , vol.22 , pp. 2006-2012
    • Hung, C.C.1    Chen, M.Y.2    Hsieh, S.M.3    Hsiao, C.F.4    Sheng, W.H.5    Chang, S.C.6
  • 10
    • 23044454558 scopus 로고    scopus 로고
    • Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy
    • Grau I., Pallares R., Tubau F., Schulze M.H., Llopis F., Podzamczer D., et al. Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy. Arch Intern Med 2005, 165:1533-1540.
    • (2005) Arch Intern Med , vol.165 , pp. 1533-1540
    • Grau, I.1    Pallares, R.2    Tubau, F.3    Schulze, M.H.4    Llopis, F.5    Podzamczer, D.6
  • 11
    • 0034679239 scopus 로고    scopus 로고
    • 23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial
    • French N., Nakiyingi J., Carpenter L.M., Lugada E., Watera C., Moi K., et al. 23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial. Lancet 2000, 355:2106-2111.
    • (2000) Lancet , vol.355 , pp. 2106-2111
    • French, N.1    Nakiyingi, J.2    Carpenter, L.M.3    Lugada, E.4    Watera, C.5    Moi, K.6
  • 12
    • 0026717596 scopus 로고
    • Thymus-independent and thymus-dependent responses to polysaccharide antigens
    • Stein K.E. Thymus-independent and thymus-dependent responses to polysaccharide antigens. J Infect Dis 1992, 165:S49-S52.
    • (1992) J Infect Dis , vol.165
    • Stein, K.E.1
  • 13
    • 0034063425 scopus 로고    scopus 로고
    • Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group
    • Black S., Shinefield H., Fireman B., Lewis E., Ray P., Hansen J.R., et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J 2000, 19:187-195.
    • (2000) Pediatr Infect Dis J , vol.19 , pp. 187-195
    • Black, S.1    Shinefield, H.2    Fireman, B.3    Lewis, E.4    Ray, P.5    Hansen, J.R.6
  • 14
    • 0242684416 scopus 로고    scopus 로고
    • Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine
    • Whitney C.G., Farley M.M., Hadler J., Harrison L.H., Bennett N.M., Lynfield R., et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003, 348:1737-1746.
    • (2003) N Engl J Med , vol.348 , pp. 1737-1746
    • Whitney, C.G.1    Farley, M.M.2    Hadler, J.3    Harrison, L.H.4    Bennett, N.M.5    Lynfield, R.6
  • 15
    • 33747025299 scopus 로고    scopus 로고
    • Safety and immunogenicity of heptavalent pneumococcal conjugate vaccine booster in taiwanese toddlers
    • Shao P.L., Lu C.Y., Chang L.Y., Huang F.Y., Lee C.Y., Hsueh P.R., et al. Safety and immunogenicity of heptavalent pneumococcal conjugate vaccine booster in taiwanese toddlers. J Formos Med Assoc 2006, 105:542-549.
    • (2006) J Formos Med Assoc , vol.105 , pp. 542-549
    • Shao, P.L.1    Lu, C.Y.2    Chang, L.Y.3    Huang, F.Y.4    Lee, C.Y.5    Hsueh, P.R.6
  • 16
    • 8344222996 scopus 로고    scopus 로고
    • Safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in Taiwanese infants
    • Shao P.L., Lu C.Y., Chang L.Y., Huang F.Y., Wang C.Y., Yang C.Y., et al. Safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in Taiwanese infants. J Formos Med Assoc 2004, 103:613-617.
    • (2004) J Formos Med Assoc , vol.103 , pp. 613-617
    • Shao, P.L.1    Lu, C.Y.2    Chang, L.Y.3    Huang, F.Y.4    Wang, C.Y.5    Yang, C.Y.6
  • 17
    • 0035851352 scopus 로고    scopus 로고
    • Randomized trial of the quantitative and functional antibody responses to a 7-valent pneumococcal conjugate vaccine and/or 23-valent polysaccharide vaccine among HIV-infected adults
    • Feikin D.R., Elie C.M., Goetz M.B., Lennox J.L., Carlone G.M., Romero-Steiner S., et al. Randomized trial of the quantitative and functional antibody responses to a 7-valent pneumococcal conjugate vaccine and/or 23-valent polysaccharide vaccine among HIV-infected adults. Vaccine 2001, 20:545-553.
    • (2001) Vaccine , vol.20 , pp. 545-553
    • Feikin, D.R.1    Elie, C.M.2    Goetz, M.B.3    Lennox, J.L.4    Carlone, G.M.5    Romero-Steiner, S.6
  • 18
    • 36348990172 scopus 로고    scopus 로고
    • Immunological efficacy of a prime-boost pneumococcal vaccination in HIV-infected adults
    • Lesprit P., Pedrono G., Molina J.M., Goujard C., Girard P.M., Sarrazin N., et al. Immunological efficacy of a prime-boost pneumococcal vaccination in HIV-infected adults. AIDS 2007, 21:2425-2434.
    • (2007) AIDS , vol.21 , pp. 2425-2434
    • Lesprit, P.1    Pedrono, G.2    Molina, J.M.3    Goujard, C.4    Girard, P.M.5    Sarrazin, N.6
  • 19
    • 50049107013 scopus 로고    scopus 로고
    • Induction of opsonophagocytic killing activity with pneumococcal conjugate vaccine in human immunodeficiency virus-infected Ugandan adults
    • Chen M., Ssali F., Mulungi M., Awio P., Yoshimine H., Kuroki R., et al. Induction of opsonophagocytic killing activity with pneumococcal conjugate vaccine in human immunodeficiency virus-infected Ugandan adults. Vaccine 2008, 26:4962-4968.
    • (2008) Vaccine , vol.26 , pp. 4962-4968
    • Chen, M.1    Ssali, F.2    Mulungi, M.3    Awio, P.4    Yoshimine, H.5    Kuroki, R.6
  • 20
    • 77950255821 scopus 로고    scopus 로고
    • Cellular CD4 T cell responses to the diphtheria-derived carrier protein of conjugated pneumococcal vaccine and antibody response to pneumococcal vaccination in HIV-infected adults
    • Rabian C., Tschope I., Lesprit P., Katlama C., Molina J.M., Meynard J.L., et al. Cellular CD4 T cell responses to the diphtheria-derived carrier protein of conjugated pneumococcal vaccine and antibody response to pneumococcal vaccination in HIV-infected adults. Clin Infect Dis 2010, 50:1174-1183.
    • (2010) Clin Infect Dis , vol.50 , pp. 1174-1183
    • Rabian, C.1    Tschope, I.2    Lesprit, P.3    Katlama, C.4    Molina, J.M.5    Meynard, J.L.6
  • 22
    • 84873092385 scopus 로고    scopus 로고
    • One-year longitudinal follow-up of serologic responses to vaccination with 7-valent pneumococcal conjugate vaccine among HIV-infected adult patients
    • Boston, United States; Sep. 12
    • Hung CC, Lu CL, Tseng YT, Chang SF, Liu WC, Wu CH, et al. One-year longitudinal follow-up of serologic responses to vaccination with 7-valent pneumococcal conjugate vaccine among HIV-infected adult patients. 50th Interscience Conference on Antimicrobial Agents and Chemotherapy; Boston, United States; Sep. 12, 2010.
    • (2010) 50th Interscience Conference on Antimicrobial Agents and Chemotherapy
    • Hung, C.C.1    Lu, C.L.2    Tseng, Y.T.3    Chang, S.F.4    Liu, W.C.5    Wu, C.H.6
  • 23
    • 52449104895 scopus 로고    scopus 로고
    • A randomized, double-blind, placebo-controlled trial to evaluate the prime-boost strategy for pneumococcal vaccination in adult liver transplant recipients
    • Kumar D., Chen M.H., Wong G., Cobos I., Welsh B., Siegal D., et al. A randomized, double-blind, placebo-controlled trial to evaluate the prime-boost strategy for pneumococcal vaccination in adult liver transplant recipients. Clin Infect Dis 2008, 47:885-892.
    • (2008) Clin Infect Dis , vol.47 , pp. 885-892
    • Kumar, D.1    Chen, M.H.2    Wong, G.3    Cobos, I.4    Welsh, B.5    Siegal, D.6
  • 24
    • 0037569243 scopus 로고    scopus 로고
    • Randomized, double-blind, controlled trial of pneumococcal vaccination in renal transplant recipients
    • Kumar D., Rotstein C., Miyata G., Arlen D., Humar A. Randomized, double-blind, controlled trial of pneumococcal vaccination in renal transplant recipients. J Infect Dis 2003, 187:1639-1645.
    • (2003) J Infect Dis , vol.187 , pp. 1639-1645
    • Kumar, D.1    Rotstein, C.2    Miyata, G.3    Arlen, D.4    Humar, A.5
  • 25
    • 69949094422 scopus 로고    scopus 로고
    • Superior immune response to protein-conjugate versus free pneumococcal polysaccharide vaccine in chronic obstructive pulmonary disease
    • Dransfield M.T., Nahm M.H., Han M.K., Harnden S., Criner G.J., Martinez F.J., et al. Superior immune response to protein-conjugate versus free pneumococcal polysaccharide vaccine in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009, 180:499-505.
    • (2009) Am J Respir Crit Care Med , vol.180 , pp. 499-505
    • Dransfield, M.T.1    Nahm, M.H.2    Han, M.K.3    Harnden, S.4    Criner, G.J.5    Martinez, F.J.6
  • 26
    • 0030900795 scopus 로고    scopus 로고
    • Safety and immunogenicity of three doses of a five-valent pneumococcal conjugate vaccine in children younger than two years with and without human immunodeficiency virus infection
    • King J.C., Vink P.E., Farley J.J., Smilie M., Parks M., Lichenstein R. Safety and immunogenicity of three doses of a five-valent pneumococcal conjugate vaccine in children younger than two years with and without human immunodeficiency virus infection. Pediatrics 1997, 99:575-580.
    • (1997) Pediatrics , vol.99 , pp. 575-580
    • King, J.C.1    Vink, P.E.2    Farley, J.J.3    Smilie, M.4    Parks, M.5    Lichenstein, R.6
  • 27
    • 0037743433 scopus 로고    scopus 로고
    • Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants with human immunodeficiency virus type 1 infection
    • Nachman S., Kim S., King J., Abrams E.J., Margolis D., Petru A., et al. Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants with human immunodeficiency virus type 1 infection. Pediatrics 2003, 112:66-73.
    • (2003) Pediatrics , vol.112 , pp. 66-73
    • Nachman, S.1    Kim, S.2    King, J.3    Abrams, E.J.4    Margolis, D.5    Petru, A.6
  • 28
    • 0036838639 scopus 로고    scopus 로고
    • Safety and immunogenicity of 23-valent pneumococcal polysaccharide vaccine in HIV-1 infected former drug users
    • Amendola A., Tanzi E., Zappa A., Colzani D., Boschini A., Musher D.M., et al. Safety and immunogenicity of 23-valent pneumococcal polysaccharide vaccine in HIV-1 infected former drug users. Vaccine 2002, 20:3720-3724.
    • (2002) Vaccine , vol.20 , pp. 3720-3724
    • Amendola, A.1    Tanzi, E.2    Zappa, A.3    Colzani, D.4    Boschini, A.5    Musher, D.M.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.